Insurance had a good day.

Insurance had a good day. Regional banks did not. Let's sort out which is which.

Travelers is your lead. The stock gapped up nine point two percent on the print, and the number that earns that move is earnings per share growth of eighty-two point nine percent year over year against a price-to-earnings ratio of ten point three. That combination — explosive earnings growth trading at a single-digit-adjacent multiple — is the kind of setup that makes a gap feel rational rather than euphoric. Net margin at fifteen point five percent is healthy for a property and casualty writer, and the Street had clearly not priced in the magnitude of the beat. The question worth sitting with is whether the underwriting improvement is structural or whether it borrowed from a benign catastrophe quarter. That is the knife. We will open the filing.

Now the regional bank cluster, and this is where the day gets interesting in the wrong direction. Citizens Financial, Fifth Third, Regions Financial, and Truist all printed and all gapped down. The revenue growth numbers across this group are dramatic on the surface — Citizens showing sixty-two point seven percent, Fifth Third and Truist both at fifty-eight point two percent, Regions at forty-five point four percent — but do not mistake rate-driven net interest income expansion for operating leverage. A lot of that topline is the Fed doing the work, not the franchises.

The number that deserves the knife today belongs to Fifth Third. Earnings per share declined five point five percent year over year in the same environment where their revenue grew fifty-eight point two percent. That gap tells you exactly what happened: credit costs, provision builds, or both absorbed the revenue tailwind before it reached the bottom line. When a bank grows revenue at nearly sixty percent and still cannot grow earnings, the cost of credit is doing serious damage — and if the rate environment softens while those provisions stay elevated, the revenue side of that equation shrinks first. That is the setup to watch.

Regions and Truist are the cleaner reads in the group. Regions at a price-to-earnings of twelve point one with fourteen percent earnings growth is not expensive. Truist at eleven point eight times with seventeen percent growth is similar. The market is saying it does not trust the durability of either, and given where credit cycles tend to go after a rate-driven expansion, the market is asking a fair question.

Abbott is the outlier here in every sense. Revenue up eight point one percent — steady, clean, diversified medtech growth. But earnings per share down sixty-one point two percent year over year is a number that demands a footnote, not a headline. That kind of earnings collapse in a company with stable revenue almost always traces to a prior-year comparison distortion — a divestiture gain, a one-time benefit, something that inflated the base. At a price-to-earnings of thirty-two point three, the Street is clearly looking through it. Worth confirming exactly what is in that base before you accept the market's shrug.

The names I am coming back for full teardowns are Travelers and Fifth Third. The gap-up and the gap between revenue and earnings respectively — those are the two stories worth the full treatment.

That is the menu. The numbers were always there — most people just do not look. See you at the next filing.